Literature DB >> 9227337

A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.

N H Senden1, E D Timmer, A de Bruïne, S S Wagenaar, H J Van de Velde, A J Roebroek, W J Van de Ven, J L Broers, F C Ramaekers.   

Abstract

Neuroendocrine-specific protein (NSP)-reticulons are endoplasmic reticulum-associated protein complexes, which have been identified as markers for neuroendocrine differentiation. In this study, the expression of two members of the family of NSP-reticulons, NSP-A and NSP-C, have been investigated in different types of lung cancer and compared with the expression patterns of five conventional neuroendocrine markers, the neural cell adhesion molecule (NCAM), synaptophysin, chromogranin A, Leu-7, and neurofilament proteins. NSP-A and NSP-C antibodies were reactive with most carcinoid tumour and small cell lung carcinoma (SCLC) cases, while atypical carcinoid tumours showed a variable expression. In the total group of neuroendocrine tumours, a high concordance of expression was found between NSP-A and NSP-C, while their expression correlated well with NCAM and synaptophysin positivity. Chromogranin A, Leu-7, and neurofilament proteins were shown to be expressed to a limited extent in these neuroendocrine tumours. In a selected group of non-SCLCs known to exhibit neuroendocrine features, NSP-A expression was detected at much higher frequency than NSP-C. In virtually all NSP-A positive cases, this expression was associated with one or more of the other neuroendocrine markers. NSP-A expression showed a stronger correlation with conventional neuroendocrine markers than NCAM. In detecting neuroendocrine differentiation in non-SCLC, NSP-A is more sensitive than synaptophysin, chromogranin A, Leu-7, and neurofilament proteins. It is concluded that NSP-reticulons are valuable markers in the diagnosis of neuroendocrine differentiation in non-SCLC and should be used in conjunction with NCAM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227337     DOI: 10.1002/(SICI)1096-9896(199705)182:1<13::AID-PATH804>3.0.CO;2-Z

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

Review 1.  Practical markers used in the diagnosis of neuroendocrine tumors.

Authors:  Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

2.  Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.

Authors:  Maode Lai; Bingjian Lü; Xiaoming Xing; Enping Xu; Guoping Ren; Qiong Huang
Journal:  Virchows Arch       Date:  2006-09-06       Impact factor: 4.064

3.  Knocking-down of Nogo-A gene expression in PC12 cell line by plasmid-based RNAi.

Authors:  Nanxiang Xiong; Jianzhang Pu; Hongyang Zhao; Qun Su; Xiaobing Jiang; Dongxiao Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

4.  Prognostic efficacy of the RTN1 gene in patients with diffuse large B-cell lymphoma.

Authors:  Mohamad Zamani-Ahmadmahmudi; Seyed Mahdi Nassiri; Amir Asadabadi
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.